Annual ROE
-110.95%
-40.56%-57.62%
31 December 2023
Summary:
Nektar Therapeutics annual return on equity is currently -110.95%, with the most recent change of -40.56% (-57.62%) on 31 December 2023. During the last 3 years, it has fallen by -75.15% (-209.92%). NKTR annual ROE is now -161.57% below its all-time high of 180.21%, reached on 31 December 2013.NKTR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-154.23%
-26.60%-20.84%
30 September 2024
Summary:
Nektar Therapeutics quarterly return on equity is currently -154.23%, with the most recent change of -26.60% (-20.84%) on 30 September 2024. Over the past year, it has dropped by -47.52% (-44.53%). NKTR quarterly ROE is now -104.84% below its all-time high of 3189.45%, reached on 31 December 2016.NKTR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.6% | -44.5% |
| 3 y3 years | -209.9% | -208.2% |
| 5 y5 years | -247.0% | -491.8% |
NKTR ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -209.9% | at low | -208.2% | at low |
| 5 y | 5 years | -247.0% | at low | -491.8% | at low |
| alltime | all time | -161.6% | +70.8% | -104.8% | +96.0% |
Nektar Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -154.23%(+20.8%) |
| June 2024 | - | -127.63%(+24.1%) |
| Mar 2024 | - | -102.84%(-18.4%) |
| Dec 2023 | -110.95%(+57.6%) | -126.07%(+18.1%) |
| Sept 2023 | - | -106.71%(+16.5%) |
| June 2023 | - | -91.58%(-7.9%) |
| Mar 2023 | - | -99.41%(+36.3%) |
| Dec 2022 | -70.39%(+18.0%) | -72.91%(-5.0%) |
| Sept 2022 | - | -76.72%(+0.9%) |
| June 2022 | - | -76.00%(+23.4%) |
| Mar 2022 | - | -61.59%(+4.8%) |
| Dec 2021 | -59.64%(+66.6%) | -58.75%(+17.4%) |
| Sept 2021 | - | -50.05%(+14.1%) |
| June 2021 | - | -43.88%(+18.6%) |
| Mar 2021 | - | -36.99%(+3.3%) |
| Dec 2020 | -35.80%(+26.9%) | -35.81%(+7.9%) |
| Sept 2020 | - | -33.20%(+8.3%) |
| June 2020 | - | -30.65%(-1.6%) |
| Mar 2020 | - | -31.14%(+10.3%) |
| Dec 2019 | -28.22%(-137.4%) | -28.24%(+8.4%) |
| Sept 2019 | - | -26.06%(+5.1%) |
| June 2019 | - | -24.79%(-153.2%) |
| Mar 2019 | - | 46.56%(-24.6%) |
| Dec 2018 | 75.47%(-168.7%) | 61.78%(-35.7%) |
| Sept 2018 | - | 96.08%(-55.4%) |
| June 2018 | - | 215.54%(-193.3%) |
| Mar 2018 | - | -230.99%(+47.3%) |
| Dec 2017 | -109.91%(-66.2%) | -156.84%(-54.4%) |
| Sept 2017 | - | -344.32%(-90.4%) |
| June 2017 | - | -3586.91%(-7.6%) |
| Mar 2017 | - | -3881.00%(-221.7%) |
| Dec 2016 | -324.73%(-14.5%) | 3189.45%(+386.5%) |
| Sept 2016 | - | 655.62%(-141.3%) |
| June 2016 | - | -1588.61%(+272.3%) |
| Mar 2016 | - | -426.67%(+104.2%) |
| Dec 2015 | -379.68%(+155.8%) | -208.98%(+35.1%) |
| Sept 2015 | - | -154.73%(-916.5%) |
| June 2015 | - | 18.95%(-83.2%) |
| Mar 2015 | - | 112.83%(-120.1%) |
| Dec 2014 | -148.40%(-182.3%) | -561.90%(-320.8%) |
| Sept 2014 | - | 254.48%(-17.6%) |
| June 2014 | - | 308.74%(-4.0%) |
| Mar 2014 | - | 321.56%(-9.0%) |
| Dec 2013 | 180.21%(-228.4%) | 353.50%(-120.7%) |
| Sept 2013 | - | -1709.35%(+307.3%) |
| June 2013 | - | -419.68%(+96.3%) |
| Mar 2013 | - | -213.83%(+58.0%) |
| Dec 2012 | -140.39%(+51.1%) | -135.33%(+41.7%) |
| Sept 2012 | - | -95.53%(+36.0%) |
| June 2012 | - | -70.25%(+13.5%) |
| Mar 2012 | - | -61.87%(-2.9%) |
| Dec 2011 | -92.89%(+136.3%) | -63.69%(+2.8%) |
| Sept 2011 | - | -61.95%(+0.3%) |
| June 2011 | - | -61.76%(+26.2%) |
| Mar 2011 | - | -48.94%(+32.7%) |
| Dec 2010 | -39.31%(-43.9%) | -36.89%(+69.7%) |
| Sept 2010 | - | -21.74%(-46.9%) |
| June 2010 | - | -40.92%(-35.8%) |
| Mar 2010 | - | -63.71%(-14.4%) |
| Dec 2009 | -70.09% | -74.45%(+472.7%) |
| Sept 2009 | - | -13.00%(-21.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | -16.48%(+0.7%) |
| Mar 2009 | - | -16.36%(-20.7%) |
| Dec 2008 | -16.97%(+14.4%) | -20.62%(-53.5%) |
| Sept 2008 | - | -44.30%(+47.5%) |
| June 2008 | - | -30.03%(+20.7%) |
| Mar 2008 | - | -24.88%(+53.7%) |
| Dec 2007 | -14.84%(-73.4%) | -16.19%(-69.3%) |
| Sept 2007 | - | -52.75%(+8.0%) |
| June 2007 | - | -48.82%(-16.2%) |
| Mar 2007 | - | -58.25%(+3.7%) |
| Dec 2006 | -55.88%(+19.9%) | -56.17%(-20.6%) |
| Sept 2006 | - | -70.72%(+8.7%) |
| June 2006 | - | -65.08%(+30.8%) |
| Mar 2006 | - | -49.77%(+12.6%) |
| Dec 2005 | -46.62%(+44.5%) | -44.21%(+106.7%) |
| Sept 2005 | - | -21.39%(+6.5%) |
| June 2005 | - | -20.08%(+9.4%) |
| Mar 2005 | - | -18.35%(-23.6%) |
| Dec 2004 | -32.27%(+28.2%) | -24.03%(+10.0%) |
| Sept 2004 | - | -21.84%(-13.3%) |
| June 2004 | - | -25.19%(-9.7%) |
| Mar 2004 | - | -27.90%(+6.6%) |
| Dec 2003 | -25.17%(-44.1%) | -26.18%(-37.9%) |
| Sept 2003 | - | -42.15%(-0.6%) |
| June 2003 | - | -42.42%(-2.4%) |
| Mar 2003 | - | -43.48%(+2.0%) |
| Dec 2002 | -45.05%(-50.6%) | -42.64%(+2.6%) |
| Sept 2002 | - | -41.54%(+6.4%) |
| June 2002 | - | -39.03%(-39.4%) |
| Mar 2002 | - | -64.39%(-22.7%) |
| Dec 2001 | -91.21%(+70.7%) | -83.33%(-9.0%) |
| Sept 2001 | - | -91.53%(-5.2%) |
| June 2001 | - | -96.58%(+39.7%) |
| Mar 2001 | - | -69.15%(+20.4%) |
| Dec 2000 | -53.44%(+40.7%) | -57.44%(-1.4%) |
| Sept 2000 | - | -58.24%(+0.7%) |
| June 2000 | - | -57.84%(+6.7%) |
| Mar 2000 | - | -54.22%(+46.3%) |
| Dec 1999 | -37.97%(+120.2%) | -37.07%(+56.0%) |
| Sept 1999 | - | -23.76%(+7.2%) |
| June 1999 | - | -22.16%(+13.6%) |
| Mar 1999 | - | -19.51%(+2.9%) |
| Dec 1998 | -17.24%(+14.2%) | -18.96%(+8.3%) |
| Sept 1998 | - | -17.51%(+11.9%) |
| June 1998 | - | -15.65%(-2.6%) |
| Mar 1998 | - | -16.07%(+2.3%) |
| Dec 1997 | -15.10%(-58.3%) | -15.71%(-23.3%) |
| Sept 1997 | - | -20.47%(-6.4%) |
| June 1997 | - | -21.88%(-20.7%) |
| Mar 1997 | - | -27.58%(-22.3%) |
| Dec 1996 | -36.17%(-16.4%) | -35.49%(+2.2%) |
| Sept 1996 | - | -34.72%(-0.5%) |
| June 1996 | - | -34.91%(+2.8%) |
| Mar 1996 | - | -33.97%(-6.4%) |
| Dec 1995 | -43.26%(+25.7%) | -36.28%(-2.3%) |
| Sept 1995 | - | -37.14%(+7.5%) |
| June 1995 | - | -34.55%(-9.7%) |
| Mar 1995 | - | -38.27%(+4.5%) |
| Dec 1994 | -34.42% | -36.62%(+74.3%) |
| Sept 1994 | - | -21.01%(+24.5%) |
| June 1994 | - | -16.88%(-23.3%) |
| Mar 1994 | - | -22.00% |
FAQ
- What is Nektar Therapeutics annual return on equity?
- What is the all time high annual ROE for Nektar Therapeutics?
- What is Nektar Therapeutics annual ROE year-on-year change?
- What is Nektar Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly ROE year-on-year change?
What is Nektar Therapeutics annual return on equity?
The current annual ROE of NKTR is -110.95%
What is the all time high annual ROE for Nektar Therapeutics?
Nektar Therapeutics all-time high annual return on equity is 180.21%
What is Nektar Therapeutics annual ROE year-on-year change?
Over the past year, NKTR annual return on equity has changed by -40.56% (-57.62%)
What is Nektar Therapeutics quarterly return on equity?
The current quarterly ROE of NKTR is -154.23%
What is the all time high quarterly ROE for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly return on equity is 3189.45%
What is Nektar Therapeutics quarterly ROE year-on-year change?
Over the past year, NKTR quarterly return on equity has changed by -47.52% (-44.53%)